← Companies|Tome Bio
To

Tome Bio

Watertown MAFounded 202150 employees
Private CapbiotechPrivateGenetic Medicine
Platform: PGI
Market Cap
N/A
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
MiritinibTOM-3941Approved3mAbKIF18ACGRPantPAHBladder Ca
ZenotuximabTOM-2846Phase 1/22VaccinePI3KαAnti-TauProstate CaALL
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)
2026-06-14
Miritinib EMA Filing
SLE
EMA Filing
2027-04-25
Miritinib Ph3 Readout
PAH
Ph3 Readout
2027-11-05
Miritinib Ph3 Readout
Bladder Ca
Ph3 Readout
2027-11-07
Zenotuximab Ph2 Data
ALL
Ph2 Data
2028-02-04
Miritinib Ph3 Readout
PAH
Ph3 Readout
2028-08-12
Zenotuximab Ph2 Data
ALL
Ph2 Data